| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.41T | 3.55T | 3.76T | 3.71T | 3.59T | 3.59T |
| Gross Profit | 1.21T | 1.17T | 1.16T | 1.14T | 1.12T | 1.08T |
| EBITDA | 466.82B | 445.80B | 370.73B | 557.97B | 446.38B | 471.68B |
| Net Income | 478.50B | 219.81B | 254.48B | 215.18B | 182.69B | 202.70B |
Balance Sheet | ||||||
| Total Assets | 3.22T | 3.50T | 3.51T | 3.27T | 3.33T | 3.19T |
| Cash, Cash Equivalents and Short-Term Investments | 455.09B | 236.08B | 342.14B | 355.90B | 484.02B | 481.83B |
| Total Debt | 134.94B | 247.09B | 245.68B | 211.18B | 285.32B | 316.32B |
| Total Liabilities | 1.19T | 1.60T | 1.60T | 1.53T | 1.62T | 1.64T |
| Stockholders Equity | 2.00T | 1.74T | 1.75T | 1.59T | 1.59T | 1.45T |
Cash Flow | ||||||
| Free Cash Flow | 265.74B | 142.98B | 113.38B | 52.23B | 105.10B | 179.18B |
| Operating Cash Flow | 391.03B | 303.88B | 309.22B | 220.33B | 248.35B | 307.95B |
| Investing Cash Flow | 48.28B | -89.18B | -157.24B | -42.81B | -59.27B | -71.56B |
| Financing Cash Flow | -419.07B | -240.45B | -181.49B | -313.58B | -193.69B | -219.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $56.96B | 18.61 | 32.85% | 2.58% | 4.62% | 1.06% | |
73 Outperform | $126.71B | 17.26 | 25.35% | 2.25% | 6.58% | 1.19% | |
70 Outperform | $224.54B | 21.51 | 35.26% | 2.21% | 4.51% | 21.89% | |
68 Neutral | $30.37B | 14.13 | 15.16% | 1.46% | 7.44% | -4.57% | |
66 Neutral | $22.69B | 15.26 | 15.82% | 2.78% | -1.97% | 48.61% | |
62 Neutral | $41.30B | 12.76 | 11.82% | 0.54% | -8.17% | 84.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |